DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,201 | -98.8% | 509 | -96.8% | 0.00% | – |
| Q2 2023 | $100,176 | -30.2% | 15,901 | -36.0% | 0.00% | – |
| Q1 2023 | $143,419 | -21.6% | 24,856 | +39.3% | 0.00% | – |
| Q4 2022 | $183,049 | -20.4% | 17,841 | +29.7% | 0.00% | – |
| Q3 2022 | $230,000 | +2.7% | 13,759 | -14.1% | 0.00% | – |
| Q2 2022 | $224,000 | -6.3% | 16,020 | +8.3% | 0.00% | – |
| Q1 2022 | $239,000 | -34.3% | 14,790 | -13.1% | 0.00% | – |
| Q4 2021 | $364,000 | +208.5% | 17,018 | +112.3% | 0.00% | – |
| Q3 2021 | $118,000 | -25.8% | 8,015 | +0.2% | 0.00% | – |
| Q2 2021 | $159,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |